The Synthetic Biology Innovation Network

SynBioBeta is the premier innovation network for innovators, investors, engineers and thinkers who share a passion for using synthetic biology to build a better, more sustainable universe.

Register for SynBioBeta 2019

Editors' picks

Partnering with Procter and Gamble: Joining together to change the world

Procter and Gamble (P&G) is one of the largest influencers in the growing market aiming to serve the consumer looking for a more natural lifestyle. They are creating new products leveraging bio-based ingredients and...

Don’t be left behind: Subscribe to the SynBioBeta weekly digest

SynBioBeta

Synthetic biology and the brain: Bryan Johnson and Ed Boyden on The Neobiological Revolution

The second day of SynBioBeta 2018 started off in a big way, with NEO.LIFE founder Jane Metcalfe moderating the keynote fireside chat “Neuroscience and synthetic biology: The neobiological revolution.” Metcalfe was...

SynbiCITE

Training the next synthetic biologists

Emily Leproust

A big IPO for synthetic biology: Twist rings the Nasdaq bell today

Ryan Cawood

Engineered cell therapies for the 21st century

“The 20th century was the century of small molecules, but the 21st century is going to be the century of biologics.” Thus began Ryan Cawood, CEO and founder of Oxford Genetics, at a special session of SynBioBeta 2018...

food crops

Tweaking just a few genes in wild plants can create new food crops – but let’s get the regulation right

Synthetic biology investors are a mix of life sciences and traditional technology investors

Entrepreneurs in synthetic biology raising new rounds of investment sometimes have a hard time finding the right investors. Traditional healthcare investors who have the expertise required to evaluate the underlying...

Kevin Holden

$1K gene therapy is one step closer with Synthego’s $110M funding round

pivot bio

Pivot Bio: Re-Awakening the Agricultural Microbiome

Press releases

Torrey Pines Investment’s i2020 Accelerator to Advance Snap Bio’s Selective Kinase Inhibitor Platform for Treatment of Endodermal Cancers and Autoimmune Diseases

Perfect Day, ADM Sign JDA to Jointly Develop and Commercialize Animal-free Dairy Proteins

AlgiKnit Closes $2.2M Seed Round to Develop Kelp-Derived Yarn

Genomatica Names Viachem Distributor for Brontide Natural Butylene Glycol in North America

Elo Life Systems Launches Australian Subsidiary in Queensland

Kraig Biocraft Laboratories Begins Scale up of Second Generation Dragon Silk

Geneious Prime Released With New Functionality for Streamlining Cloning Workflows

Ginkgo Bioworks and Glycosyn LLC Announce $14MM Deal to Scale Production of Human Milk Oligosaccharides

News by topic

Funding & Investments

Organism Engineering

Gene/Genome Synthesis & Sequencing

Genetic Tools and Technologies

Entrepreneurship

Op/Ed

Agriculture

Biopharma and Health

Chemicals

Energy

Food and Beverage

Environment

Consumer Products

Cloud Labs & Automation

Materials

Education

BioCAD & Software

Company Profile

Individual Profile

R&D Products/Services

Bioethics & Public Policy